Sharma Amit, Jamil Muhammad A, Nuesgen Nicole, Dauksa Albertas, Gulbinas Antanas, Schulz Wolfgang A, Oldenburg Johannes, El-Maarri Osman
Institute of Experimental Hematology and Transfusion Medicine, Bonn, Germany.
Department of Neurology, University Clinic Bonn, Bonn, Germany.
Mol Genet Genomic Med. 2019 May;7(5):e601. doi: 10.1002/mgg3.601. Epub 2019 Apr 6.
Long interspersed nuclear elements (LINE-1) sequences constitute a substantial portion of the human genome, and their methylation often correlating with global genomic methylation. Previous studies have highlighted the feasibility of using LINE-1 methylation to discriminate tumors from healthy tissues. However, most studies are based on only a few specific LINE-1 CpG sites.
Herein, we have performed a systematic fine-scale analysis of methylation at 14 CpGs located in the 5'-region of consensus LINE-1, in bladder, colon, prostate, and gastric tumor tissues using a global degenerate approach.
Our results reveal variable methylation levels between different CpGs, as well as some tissue-specific differences. Trends toward hypomethylation were observed in all tumors types to certain degrees, showing statistically significance in bladder and prostate tumors. Our data points toward the presence of unique LINE-1 DNA methylation patterns for each tumor type and tissue, indicating that not the same CpGs will be informative for testing in all tumor types.
This study provides an accurate guide that will help to design further assays that could avoid artifacts and explain the variability of obtained LINE-1 methylation values between different studies.
长散在核元件(LINE-1)序列构成人类基因组的很大一部分,其甲基化常与全基因组甲基化相关。先前的研究强调了利用LINE-1甲基化来区分肿瘤组织与健康组织的可行性。然而,大多数研究仅基于少数几个特定的LINE-1 CpG位点。
在此,我们使用全局简并方法,对膀胱、结肠、前列腺和胃肿瘤组织中共识LINE-1 5'区域的14个CpG位点的甲基化进行了系统的精细分析。
我们的结果揭示了不同CpG之间甲基化水平的差异,以及一些组织特异性差异。在所有肿瘤类型中均在一定程度上观察到低甲基化趋势,在膀胱和前列腺肿瘤中具有统计学意义。我们的数据表明每种肿瘤类型和组织都存在独特的LINE-1 DNA甲基化模式,这表明并非所有肿瘤类型都适用相同的CpG进行检测。
本研究提供了一个准确的指南,有助于设计进一步的检测方法,以避免假象,并解释不同研究中获得的LINE-1甲基化值的变异性。